Quotient Sciences
Garnet Valley, PA, United States quotientsciences.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Quotient Sciences provides integrated contract research, development, and manufacturing services for small molecule and synthetic peptide drug programs. It supports pharma and biotech clients across early clinical development, drug product development and manufacturing, and commercial supply from facilities in the US and UK.
Services
Drug Product Development & Manufacturing
Formulation development and drug product manufacturing services from preclinical stages through commercial supply.
Early Clinical Development
First-in-human and clinical pharmacology programs, including Phase I and Phase I/IIa studies.
Translational Pharmaceutics® Integrated Drug Development
An integrated approach combining formulation development, drug product manufacturing, and clinical testing in one program.
Clinical Pharmacology Studies
Exploratory and regulatory-driven Phase 1 clinical pharmacology studies such as DDI, human ADME, BA/BE, food effect, and TQT.
Human ADME Studies
Integrated human mass balance and 14C radiolabeled ADME studies for regulatory filings.
Pharmacy Compounding
Integrated pharmacy compounding and GMP manufacturing to support first-in-human clinical testing and later proof-of-concept trials.
Commercial Drug Product Manufacturing
Commercial manufacturing and sustained supply for solid oral dosage forms, including niche and small-volume products.
CDMO: development & manufacturing
Scale-Up & CDMO Tech-Transfer
Technology transfer and scale-up support from lab or pilot scale into registration batches and commercial supply.
8 more services
- High Potency API Handling & Drug Product Manufacturing
- Pediatric Formulation Development
- Drug Substance Synthesis & Manufacturing
- Preclinical Technology Screening
- Clinical Trial Manufacturing
- Commercial Manufacturing
- Global Clinical Trial Supplies
- AI-Enhanced Formulation Development
- Turnaround
- Less than seven days
- What to send
- 14C drug products tailored to specific program requirements
- IV products where appropriate for human ADME studies
- Minimums and prices
- $8-30 million savings in runway costs by reaching proof-of-concept sooner
Capabilities
- Assays and studies
- Small molecules
- Peptides
- Single ascending dose (SAD)
- Multiple ascending dose (MAD)
- Drug-drug interaction (DDI)
- Human ADME
13 more
- Bioavailability/bioequivalence (BA/BE)
- Food effect
- Thorough QT (TQT)
- Bioanalysis
- Pharmacokinetics
- Statistics
- Clinical programming
- Pharmacodynamic studies
- Biomarker studies
- Pharmacokinetic studies
- Taste assessment
- Tablet dissolution
- In vitro drug release
- Scale and capacity
- More than 1,300 Phase I studies delivered
- Database of 31,500+ active healthy volunteers
- Two Philadelphia sites approved for Phase I–III clinical manufacturing and commercial drug product manufacturing
- Third site in the planning stages
- Batch sizes from less than 1 kg to over 400 kg
- Up to 500 kg for solid oral dosage forms in commercial drug product
- 2,500 ft² compounding pharmacy
- Less than seven days for manufacture and release of drug products
- Therapeutic areas
- Inflammation
- Metabolic diseases
- CNS disorders
- Oncology
- Rare diseases
- GI/gastroenterology
10 more
- Cardiovascular
- Dermatology
- Endocrinology
- GI
- Haematology
- Immunology
- Hepatology
- Infectious disease
- Nephrology
- Pediatrics
Instruments and platforms
- Translational Pharmaceutics®
- Synthesis-to-Clinic®
- PBLEC standards
- USP 795/797/800 clean room
- Proprietary AI algorithm
- Digital twin
Modalities and species
- Modalities
- Small molecule
- Peptide
- Species and models
- Healthy volunteers
- Special populations
- Patient cohorts
- Healthy smokers
- Healthy elderly
- High BMI
4 more
- Post-menopausal women
- Japanese
- Chinese
- Healthy participants
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: drug product manufacturing
Details
- Type
- CRDMO
- Founded
- 1990
- Based in
- Garnet Valley, PA, United States
- Sites
- Miami, United States
- Nottingham, United Kingdom
- Philadelphia, United States
- Boothwyn, United States
- Philadelphia, PA, United States
- Serves
- US, UK, global
Public records
- Parent company
- QUOTIENT SCIENCES LIMITED · GB GLEIF
- Biocom California CRO directory
- drug development, Drug Product Manufacturing, drug substance API manufacturing, Formulation Development, small molecule source
- FDA drug establishment registration
- 3003882011 · ANALYSIS; MANUFACTURE source
- CMS CLIA laboratory
- 10D1098266 · MIAMI source